Dosmalfate, also known as sulglycotide, is an intriguing pharmaceutical compound primarily used for its gastroprotective properties. It is often employed in the treatment of conditions such as
gastric ulcers and
gastritis. To grasp the mechanism of Dosmalfate, it is important to delve into its pharmacokinetics and the underlying biochemical interactions that confer its therapeutic benefits.
Dosmalfate belongs to the family of cytoprotective agents, which function by safeguarding the gastric mucosa against various injurious agents. The compound itself is a complex aluminum salt of sulfated disaccharide. Unlike antacids, which neutralize stomach acid, or
H2-receptor antagonists and
proton pump inhibitors, which reduce acid production, Dosmalfate works by enhancing the body's natural defense mechanisms in the gastrointestinal tract.
One of the primary mechanisms through which Dosmalfate functions is the formation of a protective barrier over the gastric mucosa. When introduced into the stomach, Dosmalfate undergoes a chemical reaction in the acidic environment, leading to the release of aluminum ions and the sulfated disaccharide. These components then form a viscous, gel-like layer that adheres to the ulcerated or inflamed mucosa. This barrier acts as a physical shield, protecting the underlying tissue from further damage by gastric acid, pepsin, and bile salts.
Moreover, Dosmalfate has been shown to promote the secretion of mucus and bicarbonate, both of which are crucial for maintaining the integrity of the gastric lining. Mucus serves as an additional physical barrier, while bicarbonate neutralizes acid in the immediate vicinity of the mucosal surface. This dual action helps to create a more favorable environment for tissue healing and regeneration.
Another significant aspect of Dosmalfate's mechanism of action is its ability to bind to and sequester bile acids. Bile acids can contribute to
mucosal injury by disrupting the lipid bilayer of epithelial cells and increasing permeability. By binding to these bile acids, Dosmalfate prevents them from exerting their harmful effects on the gastric and duodenal lining.
Additionally, Dosmalfate is known to stimulate the release of prostaglandins within the gastric mucosa. Prostaglandins are lipid compounds that play a pivotal role in promoting mucosal blood flow, enhancing mucus and bicarbonate secretion, and modulating inflammatory responses. The increased production of prostaglandins further supports mucosal defense and facilitates the healing process.
It is also worth mentioning that Dosmalfate exhibits some antibacterial properties, particularly against Helicobacter pylori, a bacterium implicated in the pathogenesis of
peptic ulcers and
chronic gastritis. By inhibiting the growth of H. pylori, Dosmalfate contributes to the reduction of bacterial load and the associated inflammatory response.
In summary, the mechanism of Dosmalfate is multifaceted and involves several interrelated actions. Its primary effect is the formation of a protective barrier over the gastric mucosa, shielding it from acid and other injurious agents. Additionally, Dosmalfate enhances mucus and bicarbonate secretion, binds to bile acids, stimulates prostaglandin production, and exhibits antibacterial properties. Together, these actions work synergistically to protect the gastric lining, promote healing, and alleviate symptoms associated with gastric ulcers and gastritis. Understanding these mechanisms provides valuable insights into the therapeutic potential of Dosmalfate and its role in managing gastrointestinal disorders.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


